iSpecimen, Inc. (ISPC)
1.57
-0.12
(-7.10%)
USD |
NASDAQ |
Aug 24, 16:00
1.53
-0.04
(-2.55%)
After-Hours: 20:00
iSpecimen Profit Margin (Quarterly) : -897.2% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -897.2% |
| March 31, 2026 | -1.46K% |
| December 31, 2025 | -9.65K% |
| September 30, 2025 | -2.61K% |
| June 30, 2025 | -146.9% |
| March 31, 2025 | -156.8% |
| December 31, 2024 | -409.8% |
| September 30, 2024 | -54.09% |
| June 30, 2024 | -73.65% |
| March 31, 2024 | -126.7% |
| December 31, 2023 | -119.3% |
| September 30, 2023 | -76.00% |
| June 30, 2023 | -214.4% |
| March 31, 2023 | -82.43% |
| Date | Value |
|---|---|
| December 31, 2022 | -72.93% |
| September 30, 2022 | -119.8% |
| June 30, 2022 | -111.5% |
| March 31, 2022 | -94.64% |
| December 31, 2021 | -80.44% |
| September 30, 2021 | -57.13% |
| June 30, 2021 | -48.04% |
| March 31, 2021 | -133.7% |
| December 31, 2020 | -58.63% |
| September 30, 2020 | -55.39% |
| June 30, 2020 | -11.57% |
| March 31, 2020 | -95.69% |
| December 31, 2019 | -104.5% |
| September 30, 2019 | -304.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| LataMed AI Corp. | -- |
| SCWorx Corp. | -17.14% |
| Health Catalyst, Inc. | -57.51% |
| GoodRx Holdings, Inc. | 4.26% |
| Claritev Corp. | -23.00% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -611.8% |
| Return on Assets | -148.1% |
| Return on Invested Capital | -535.3% |
| Gross Profit Margin (Quarterly) | -87.43% |
| Operating Margin (Quarterly) | -897.3% |
| Return on Net Operating Assets | -251.3% |